Blazar B, Hill G, Murphy W
Nat Rev Clin Oncol. 2020; 17(8):475-492.
PMID: 32313224
PMC: 7901860.
DOI: 10.1038/s41571-020-0356-4.
Galteau M, Shamsa F
Eur J Clin Pharmacol. 2003; 59(10):713-33.
PMID: 14605790
DOI: 10.1007/s00228-003-0690-3.
Br Med J. 1970; 4(5727):65.
PMID: 5471768
PMC: 1819648.
Hunter J, Maxwell J, Stewart D, Parsons V, Williams R
Br Med J. 1971; 4(5781):202-4.
PMID: 5115570
PMC: 1799298.
DOI: 10.1136/bmj.4.5781.202.
Hunter J, Thompson R, Rake M, Williams R
Br Med J. 1971; 2(5760):497-9.
PMID: 4931488
PMC: 1795997.
DOI: 10.1136/bmj.2.5760.497.
Enzyme induction and man.
Hunter J
Ir J Med Sci. 1974; 0(0):suppl:85-92.
PMID: 4851878
DOI: 10.1007/BF02938130.
Enzyme induction and medical treatment.
Hunter J
J R Coll Physicians Lond. 1974; 8(2):163-74.
PMID: 4810112
PMC: 5366562.
Urinary D-glucaric acid excretion and acetanilide pharmacokinetics before and during diphenylhydantoin administration.
Cunningham J, Evans D
Eur J Clin Pharmacol. 1974; 7(5):387-91.
PMID: 4417891
DOI: 10.1007/BF00558212.
Phenobarbital-induced alterations in vitamin D metabolism.
Hahn T, Birge S, Scharp C, Avioli L
J Clin Invest. 1972; 51(4):741-8.
PMID: 4335442
PMC: 302186.
DOI: 10.1172/JCI106868.
Osteomalacia after prolonged glutethimide administration.
Greenwood R, Prunty F, Silver J
Br Med J. 1973; 1(5854):643-5.
PMID: 4144245
PMC: 1588622.
DOI: 10.1136/bmj.1.5854.643.
Inducing effect of feprazone on hepatic drug-metabolizing enzymes in man.
Morita K, Shibata H, Ono T, Shimakawa H
Eur J Clin Pharmacol. 1986; 31(1):117-8.
PMID: 3780819
DOI: 10.1007/BF00870999.
Comparison study of the sensitivities of some indices of DDT exposure in human blood and urine.
Nhachi C, Loewenson R
Bull Environ Contam Toxicol. 1989; 43(4):493-8.
PMID: 2804389
DOI: 10.1007/BF01701925.
The effect of DDT on hepatic microsomal drug-metabolising enzymes in the baboon: comparison with the rat.
Down W, Chasseaud L
Bull Environ Contam Toxicol. 1978; 20(5):592-601.
PMID: 104750
DOI: 10.1007/BF01683570.
Evaluation of in vivo parameters of drug metabolizing enzyme activity in man after administration of clemastine, phenobarbital or placebo.
Hildebrandt A, Roots I, Speck M, Saalfrank K, Kewitz H
Eur J Clin Pharmacol. 1975; 8(5):327-36.
PMID: 9297
DOI: 10.1007/BF00562658.
